Tioconazole Workflows for Antifungal Research
2026-08-28
Build more reproducible antifungal assays with Tioconazole by connecting cytochrome P450 inhibition to ergosterol-dependent phenotypes, concentration control, and orthogonal readouts. This workflow also shows how metabolic-stress concepts from leukemia research can inform, but not replace, validation in fungal systems.
Cardamomin in Oxidative Injury and Ischemic Stroke
2026-08-28
This study evaluates cardamomin from Amomum villosum in hydrogen peroxide-stressed BV-2 cells and a rat model of permanent cerebral ischemia. Its main contribution is a mechanism-based link between MEK/ERK-mediated NRF2 activation, suppression of oxeiptosis and parthanatos, and reduced ischemic brain injury.
Saquinavir A3790 for Reliable Cell Assays
2026-08-27
Learn how Saquinavir (SKU A3790) can be integrated into reproducible cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide links compound handling, membrane-interaction evidence, assay controls, and supplier documentation to practical decisions in HIV infection research, antiretroviral drug research, and exploratory cancer research.
Phosphatase Inhibitor Cocktail: Protocol Guide
2026-08-27
Phosphatase Inhibitor Cocktail (2 Tubes, 100X) helps limit post-lysis dephosphorylation during protein extraction and downstream phosphoprotein workflows. It is intended for research assays such as immunoblotting, immunoprecipitation, kinase activity assays, and mass spectrometry, but it is not a diagnostic or medical reagent and requires assay-specific compatibility checks.
Angiotensin III: Practical RAAS Assay Workflows
2026-08-26
Build reproducible RAAS experiments around Angiotensin III, from receptor-resolved signaling and aldosterone assays to pressor and neuroendocrine models. The workflow also shows how recent spike–receptor binding findings can inform carefully controlled cross-domain assays without overstating translational evidence.
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-08-26
The reference review presents dabigatran etexilate as a clinically important advance in anticoagulation: an orally absorbed prodrug that produces rapid, predictable inhibition of thrombin without CYP450-dependent metabolism or routine INR-based dose adjustment. Its analysis connects molecular pharmacology with evidence in venous thromboembolism prevention, atrial fibrillation, and acute VTE treatment while emphasizing renal function and bleeding risk as essential determinants of use.
HRP Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-08-25
HRP Goat Anti-Rabbit IgG (H+L) Antibody, SKU K1223, provides an affinity-purified HRP secondary reagent for detecting rabbit primary antibodies in Western blot, ELISA, IHC, and immunocytochemistry. It is intended for research workflows only, not diagnostic or medical use, and assay-specific dilution and cross-reactivity must be validated because no directly matched paper evidence is available for product-specific performance claims.
Annexin V-FITC Apoptosis Kit in AD Research
2026-08-25
Learn how the Annexin V-FITC/PI Apoptosis Assay Kit can map viable, early apoptotic, and membrane-compromised states in Alzheimer’s disease cell models. This guide connects phosphatidylserine externalization to oxidative stress, mitochondrial injury, and evidence-based assay interpretation.
2',7'-Dichlorofluorescein diacetate ROS Assay
2026-08-24
Learn how to use 2',7'-Dichlorofluorescein diacetate for reproducible intracellular ROS measurement across microscopy, flow cytometry, and plate-based workflows. The guide translates a pH/ROS-responsive pancreatic cancer nanocarrier study into practical assay controls, optimization decisions, and interpretation limits.
7-Ethyl-10-hydroxycamptothecin in Translation
2026-08-23
A mechanistic and strategic guide to using 7-Ethyl-10-hydroxycamptothecin, also known as SN-38, in advanced colon cancer research, with emphasis on topoisomerase I inhibition, FUBP1 pathway interference, cell-cycle arrest, apoptosis, experimental design, and translational limits.
Hypoxia and Immunometabolism in Tumors
2026-08-22
This 2025 review frames tumor hypoxia and immune metabolism as a reciprocal system that links oxygen limitation, nutrient competition, metabolic reprogramming, and immune suppression. Its practical value lies in connecting HIF-associated signaling with tumor and immune-cell behavior while identifying measurement strategies and therapeutic considerations for metabolism-focused cancer research.
In Vitro Cancer Drug Response: Beyond Viability
2026-08-21
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these measures capture overlapping but nonidentical aspects of cancer-cell drug response. Its central implication is methodological: growth inhibition and cell death should be measured and interpreted as separate, time-dependent outcomes rather than treated as interchangeable endpoints.
FITC Goat Anti-Mouse IgG (H+L): Assay Design
2026-08-21
Learn how the FITC Goat Anti-Mouse IgG (H+L) Antibody can connect fluorescence assay design with mechanistic antiviral research. This guide focuses on interpreting signal architecture, validating MAVS pathway findings, and choosing controls beyond routine protocol execution.
NMDA–Cav2.1 Control of PV-Interneuron GABA Release
2026-08-20
Singh et al. show that developmental NMDAR signaling in prospective cortical parvalbumin interneurons is required for maturation of Cav2.1-dependent GABA release, rather than merely for maintaining excitability or calcium availability. The study combines cell-type-specific genetics, paired patch-clamp recordings, pharmacology, and rescue experiments to connect NMDAR hypofunction with impaired inhibitory synaptic maturation relevant to schizophrenia models.
Amyloid Beta-Peptide (1-40) (human) in Cell Assays
2026-08-20
Learn how Amyloid Beta-Peptide (1-40) (human), SKU A1124, can reduce interpretation problems in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects peptide handling, aggregation-state control, vehicle selection, and orthogonal fluorescence readouts to reproducible Alzheimer’s disease research.
459 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page